Download - Cervical Cancer
![Page 1: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/1.jpg)
Cervical Cancer
![Page 2: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/2.jpg)
Introduction
• Third most common gynecologic cancer– Also 3rd cause of death in US– Second most common type in places where there
is no preventive screening– HPV is central to its development; detected 99.7%
![Page 3: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/3.jpg)
Epidemiology
• 530,000 new case cases worldwide, and for 275,00 deaths in 2008.
• Mortality rate 52% worldwide• 75% decrease due to vaccination and
screening in the past 50 years.• In Women:– 10th most common type– developed country– 2nd most common type – developing countries
![Page 4: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/4.jpg)
![Page 5: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/5.jpg)
Risk Factors
1. Early onset of sexual activity – by 2 fold inc2. Multiple Sexual partners – by 2 fold inc3. Hx of STI (e.g., Chlamydia, genital herpes)4. Hx of Vulvar or vaginal squamous
intraepithelial neoplasia or cancer5. Immunosuppression (e.g., AIDS)6. Oral contraceptives, adenocarcinoma – (≥5 years' use versus never-use: RR 1.90, 95% CI
1.69-2.13).
![Page 6: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/6.jpg)
Pathogensis
• Four major steps in cervical cancer development:– Oncogenic HPV infection of metplastic epithelium
at transformation zone– Persistence of HPV infection– Progression of a clone epithelial cells from
persistent viral infection to precancer– Development of carcinoma and invasion through
the basement membrane.
![Page 7: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/7.jpg)
Oncogenic HPV
![Page 8: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/8.jpg)
Histopathology
![Page 9: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/9.jpg)
Route of Spread
• Can spread by – Direct extention: involve the uterine corpus,
vagina parametria, perotoneal cavity, bladder and recturm
– Lymphatic: obtruae lymph node pevlic side wall of common illiac, and then paraortic
– Hematogenous: lungs, liver, and bone. • Less frequent: bowel, adrenal glands, spleen and brain
![Page 10: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/10.jpg)
![Page 11: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/11.jpg)
Clinical Manifestations
• Early is frequently asymptomatic• Common symptoms at presentation:
– Irregular or heavy vaginal bleeding– Post-coital bleeding– Some present with vaginal discharge:
• Can be watery, purulent and malodorous– Non specific finding for vaginitis and cervicitis
• Advance disease:– Back pain radiate to posterior lower extremities– Bowel or urinary symptoms:
• Pressure related complaints, hematuria, hematochezia, vaginal passage of urine or stool (Uncommon and suggest advance)
• Asymptomatic women – can be discovered due to screen
![Page 12: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/12.jpg)
Diagnosis
• By biopsy, colposcopy with direct biopsy• Physical:
– Pelvic exam: visualization of cervix upon speculum examination may reveal a visible lesion, or sometimes normal appearance• Lesion that is raised friable or has appearance of condyloma should be
biopsied.• Do not biopsy Nabothian Cyst
– Thorough pelvic exam, includes rectovaginal examination and assessment of tumour size and vaginal parametrial involvement for staging
• Cervical cytology – principal of screening (conjoined with HPV testing)
![Page 13: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/13.jpg)
Colposcopy
![Page 14: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/14.jpg)
Nabothian Cyst
![Page 15: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/15.jpg)
• Endophytic tumors can result in an enlarged, indurated cervix whose surface is smooth, referred to as a “barrel shaped cervix”.
![Page 16: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/16.jpg)
![Page 17: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/17.jpg)
![Page 18: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/18.jpg)
![Page 19: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/19.jpg)
![Page 20: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/20.jpg)
![Page 21: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/21.jpg)
Staging: • Clinical preferred on surgical• Accurate pretreatment staging of cervical
cancer is critical, as it determines therapy (ie, surgery, chemoradiation, chemotherapy alone) and prognosis
• Diagnosis (histology) the extent of disease
![Page 22: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/22.jpg)
Two parallel clinical stages:
• FIGO system:– based upon• physical examination• Endoscopic diagnostic procedures • Imaging studies
• TNM system:– “T" stages correspond to the FIGO stages with the
exception of carcinoma in situ– Includes a pathologic staging system (pTNM)
![Page 23: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/23.jpg)
STAGING PROCEDURE• Physical examination
– Pelvic examination– Examination for distant metastases
• Cervical biopsy– Colposcopy with directed cervical biopsy– Endocervical curettage– Conization
• Endoscopy– Hysteroscopy– Cystoscopy– Proctoscopy
• Imaging studies– Intravenous pyelogram (IVP) … (CT, or MRI)– Imaging with a plain chest radiograph and radiograph of the skeleton
![Page 24: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/24.jpg)
Adequacy of Colposcopy
• Must evaluate the entirety of the lesion– Can you follow the entire lesion?– Does it go past the SCJ and into the endocervix?– Does it move into the vagina?
• Must evaluate the entirety of the SCJ– Is it obscured by prior treatments?– Does it recede into the endocervix?– Proper evaluation of both the lesion and the SCJ is an adequate
colposcopy
Failure of either criteria is an inadequate colposcopy and leads to changes
![Page 25: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/25.jpg)
Colposcop
STAGING PROCEDURE
![Page 26: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/26.jpg)
STAGING PROCEDURE
![Page 27: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/27.jpg)
Staging For Cervical Cancer
![Page 28: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/28.jpg)
Stages of Cervical Cancer
![Page 29: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/29.jpg)
Cervical CancerTreatment Modalities
1.Surgery , Radical Hysterectomy + PLND .
2. Chemo / Radiation Therapy , including :
A. Tele - therapy ( External Radiation) .
B. Brachy- therapy ( Intracavitary ) . C. Neo-adjuvant Chemotherapy .
![Page 30: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/30.jpg)
Types Of Hysterectomies
![Page 31: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/31.jpg)
Radical Hysterectomy
Complications:
Bleeding ! Bladder ! Bowel ! General !
Type I Type II Type III type IV
![Page 32: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/32.jpg)
Radical Hysterectomy
![Page 33: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/33.jpg)
Types Of Radical Hysterectomy
![Page 34: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/34.jpg)
Radiation Therapy Complications
External : Abdominal
organs ! Bone Marrow ! Bowel ( Small /
Large). Skin !
Internal : Cystitis ! Proctitis ! Vaginal tissues !
![Page 35: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/35.jpg)
Decision depends on : 1. Patient age . 2. Stage of disease . 3. Performance status
. 4. Other factors .
Cervical CancerTreatment Modalities
![Page 36: Cervical Cancer](https://reader034.vdocument.in/reader034/viewer/2022051609/546fce96af7959f3518b471e/html5/thumbnails/36.jpg)
Work UpA chest X-ray looks for spread to the lungs. IVP can be used to look at the urinary
tract. A CT scan is necessary !!!The bladder and urethra are evaluated by
cystoscopy.The rectum is evaluated by a procto
signoidoscopy. Lymph nodes are evaluated by CT scans,
invasion of soft tissues is evaluated by MRI scans !
??? Distal metastases is evaluated by PET scans.